A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates

Emmanuelle V LeBlanc; Che C Colpitts

doi:10.1016/j.xcrm.2021.100223

A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates

Cell Rep Med. 2021 Mar 16;2(3):100223. doi: 10.1016/j.xcrm.2021.100223.

Authors

Emmanuelle V LeBlanc¹, Che C Colpitts¹

Affiliation

¹ Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada, K7L 3N6.

Abstract

Accurate population surveillance of SARS-CoV-2 infection has been hampered by limited testing and inadequate serological assays. In a recent issue of Med, Hippich et al.¹ describe a two-step antibody test with 100% specificity, revealing higher-than-reported SARS-CoV-2 exposure rates in children.

MeSH terms

Antibodies, Viral / blood*
Asymptomatic Diseases
COVID-19 / diagnosis*
COVID-19 / epidemiology
COVID-19 / virology
COVID-19 Serological Testing
Child
Diabetes Mellitus, Type 1 / pathology
Female
Humans
Male
SARS-CoV-2 / genetics
SARS-CoV-2 / immunology*
SARS-CoV-2 / isolation & purification

Substances

Antibodies, Viral